Measles Market-Top Market Players Profiles and Future Prospects with Impact Analysis & Industry Opportunities by 2023
Market Research Future recently presented Global Measles Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2023.
Global Measles Market -Highlights
Measles or rubeola is a contagious viral infection majorly affects the respiratory system. An infected person can release the pathogens into the air when they cough or sneeze. The main symptom of measles is an itchy skin rash. The rash often starts on the head and moves down the body.
GET FREE SAMPLE REPORT AT https://www.marketresearchfuture.com/sample_request/4449
Other symptoms include: fever, cough, runny nose, and conjunctivitis. Measles is one of the leading causes of death in children.
According to the World Health Organization (WHO), in 2014, 114,900 global deaths related to measles was reported and that most of the patients were under the age of 5.
Global Measles Market -Key Players
Abbott (US)
Novartis AG (Switzerland)
Biomedical diagnostics (US)
ohnson & Johnson Services, Inc. (US)
Sanofi (US)
Merck & Co., Inc. (US)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark),
MedImmune (US Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions Inc. (US)
GlaxoSmithKline plc (US)
Global Measles Market –Growth and Analysis
Increasing prevalence of the disease and changing lifestyle are the major drivers for the growth of the market. Moreover, increasing prevalence of immunological diseases and increasing government support for research & development have fuelled the market growth.
However, high cost of the treatment may hinder the growth of the market over the review period.The global measles market is expected to grow at a CAGR of ~5.1 % during the forecast period 2017-2023.
Global Measles Market -Regional Analysis
The Americas account for a significant share of the market owing to the presence of huge patient population with various diseases. According to the Autoimmune Registry, in 2012, 14.7 million people in the US were suffering from autoimmune diseases.
Auto immune diseases is one of the major factors responsible for measles. Additionally, high healthcare spending and increasing government support for research & development have fueled the market growth in this region.
Europe holds the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for measles.
India and China are the major contributor to the growth of the market owing to developing healthcare sector and increasing health care expenditure.
The Middle East & Africa holds the lowest share in the market due to limited availability of medical facilities.
UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Global Measles Market -Segmentation
The Global Measles Market has been segmented on the basis of types, treatment, and end users.
On the basis of type, the market is segmented into red measles and German measles. On the basis of treatment, the market is segmented into antibiotic treatment, antiviral treatment, vaccine, and others.
Vaccines are further segmented into mumps measles rubella vaccine, live (MMR-II) & mumps measles rubella, and varicella virus vaccine (Proquad).On the basis of end user, the market is segmented into hospital, clinics, and others.
OBTAIN REPORT DETAILS AT https://www.marketresearchfuture.com/reports/measles-market-4449
Major Points form TOC for Measles Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
…Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Global Measles Market -Highlights
Measles or rubeola is a contagious viral infection majorly affects the respiratory system. An infected person can release the pathogens into the air when they cough or sneeze. The main symptom of measles is an itchy skin rash. The rash often starts on the head and moves down the body.
GET FREE SAMPLE REPORT AT https://www.marketresearchfuture.com/sample_request/4449
Other symptoms include: fever, cough, runny nose, and conjunctivitis. Measles is one of the leading causes of death in children.
According to the World Health Organization (WHO), in 2014, 114,900 global deaths related to measles was reported and that most of the patients were under the age of 5.
Global Measles Market -Key Players
Abbott (US)
Novartis AG (Switzerland)
Biomedical diagnostics (US)
ohnson & Johnson Services, Inc. (US)
Sanofi (US)
Merck & Co., Inc. (US)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark),
MedImmune (US Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions Inc. (US)
GlaxoSmithKline plc (US)
Global Measles Market –Growth and Analysis
Increasing prevalence of the disease and changing lifestyle are the major drivers for the growth of the market. Moreover, increasing prevalence of immunological diseases and increasing government support for research & development have fuelled the market growth.
However, high cost of the treatment may hinder the growth of the market over the review period.The global measles market is expected to grow at a CAGR of ~5.1 % during the forecast period 2017-2023.
Global Measles Market -Regional Analysis
The Americas account for a significant share of the market owing to the presence of huge patient population with various diseases. According to the Autoimmune Registry, in 2012, 14.7 million people in the US were suffering from autoimmune diseases.
Auto immune diseases is one of the major factors responsible for measles. Additionally, high healthcare spending and increasing government support for research & development have fueled the market growth in this region.
Europe holds the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for measles.
India and China are the major contributor to the growth of the market owing to developing healthcare sector and increasing health care expenditure.
The Middle East & Africa holds the lowest share in the market due to limited availability of medical facilities.
UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Global Measles Market -Segmentation
The Global Measles Market has been segmented on the basis of types, treatment, and end users.
On the basis of type, the market is segmented into red measles and German measles. On the basis of treatment, the market is segmented into antibiotic treatment, antiviral treatment, vaccine, and others.
Vaccines are further segmented into mumps measles rubella vaccine, live (MMR-II) & mumps measles rubella, and varicella virus vaccine (Proquad).On the basis of end user, the market is segmented into hospital, clinics, and others.
OBTAIN REPORT DETAILS AT https://www.marketresearchfuture.com/reports/measles-market-4449
Major Points form TOC for Measles Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
…Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com